Regramostimum

Regramostimum Uses, Dosage, Side Effects, Food Interaction and all others data.

Regramostimum (GM-CSF) is a differentially glycosylated factor produced mainly by activated T cells and macrophages. Endothelial cells and fibroblasts can also produce GM-CSF after exposure to TNF-α, IL-1, IL-2 and IFN-γ. GM-CSF is found associated with extracellular matrix and in membrane-bound formats too. GM-CSF stimulates proliferation, activation and differentiation of macrophages and granulocytes and their progenitors.

Trade Name Regramostimum
Generic Regramostim
Regramostim Other Names GM-CSF (CHO cell), Regramostim, Regramostime, Regramostimum, rhGm-CSF
Type
Groups Investigational
Therapeutic Class
Manufacturer
Available Country
Last Updated: September 19, 2023 at 7:00 am
Regramostimum
Regramostimum

Uses

Investigated for use/treatment in adverse effects (chemotherapy) and bone marrow transplant.

How Regramostimum works

This drug activates mononuclear phagocytes, promotes migration of epithelial cells, and further regulates cytokine production. In 2 recent placebo-controlled studies involving venous leg ulceration, subcutaneous perilesional injections of recombinant human granulocyte-macrophage colony-stimulating factor were found to be significantly better than placebo in the time to complete wound healing. In other studies, recombinant human granulocyte-macrophage colony-stimulating factor was administered topically to wounds. Several case reports have also demonstrated the use of recombinant human granulocyte-macrophage colony-stimulating factor for postsurgical wounds, chronic leg ulcers of sickle cell anemia patients, and refract and refractory pyoderma gangrenosum.

Innovators Monograph

You find simplified version here Regramostimum

*** Taking medicines without doctor's advice can cause long-term problems.
Share